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Background: Clinical hypothyroidism affects various aspects of cognitive 
and affective brain function. The most severe hypothyroidism may also 
mimic a picture of melancholic depression and dementia. Subclinical 
hypothyroidism (SHT) is characterized by elevated TSH levels despite 
normal thyroid hormone concentrations. The aim of this research is to 
verify the presence of a typical psychophysiological pattern  in SHT 
patients.  
Methods: Since 1998 fifty patients who underwent surgeries at the 
Department of Endocrinology, University of Pisa, diagnosed with SHT, 
were subsequently recruited. Subjects underwent an inspection of the 
reported symptoms using the Crown & Crisp Experiential Index, and a 
psychophysiological assessment with a simultaneous recording of the 
parameters Skin Conductance Level/ Response (SCL/SCR), Surface Frontal 
Electromyogram (EMG), Peripheral Temperature (PT), Heart Rate (HR). 
As a control group, fifty subjects without endocrine disorders were 
subsequently recruited.  
Results: Data shows  little difference in levels in hormonal assays except 
for TSH. There is also a significant elevation of some of the CCEI 
subscales: Anxiety, Depression, and Somatic Complaints. At the autonomic 
level, there is a general pattern of excessive arousal with significant 
differences in SCL/SCR, HR, and PT.  
Conclusions: A  first data  interpretation is that in sub-clinical 
hypothyroidism, the body tries to support and integrate the general lack of 
energy with an acceleration of the autonomic activity. This condition of 
initial arousal could be a useful indicator in order to monitor the treatment 
course and its effectiveness on the pathological evolution.  
 
Copy Right, IJAR, 2016,. All rights reserved 
 
 
INTRODUCTION 
 
Subclinical hypothyroidism (SHT) occurs when serum TSH concentrations are raised and serum thyroid hormone 
concentrations are normal; it occurs in 4–20% of the adult population and may have  various causes. In about 60–
80% of cases, the disorder is associated with antithyroid peroxidase antibodies, a marker of chronic lymphocytic 
(Hashimoto’s) thyroiditis. Thyroid hormones exert important effects on the adult brain and it is widely accepted that overt 
hypothyroidism is associated with psychological disorders and neuropsychiatric symptoms. Neuropsychiatric symptoms refer 
to a spectrum of emotional and cognitive problems directly related  to changes in the brain of multiple factors (Cooper, 
Biondi, 2012; Almeida et al., 2007; Monzani et al., 1991; Monzani et al, 1993 May; Chueire et al., 2007; Davis et al., 
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2003; De Jongh et al., 2011 ; Demartini et al., 2010 ). 
Hypothyroidism affects various aspects of cognitive and affective brain function. The most severe hypothyroidism may also 
mimic a depiction of melancholic depression and dementia. The patient is frequently characterized by  dysphoria, 
anxiety, restlessness, emotional liability and impaired concentration (Gulseren et al., 2006; Ge et al.,2013). 
 In hypothyroid patients, everything seems to move in slow motion, frequent mood is depressed and typical 
symptoms of major depression may be present (DSM-V, APA, 2013). They are apathetic, and they report fatigue 
and loss of interest in sex. Some have suicidal thoughts, and many complaints of memory loss and have symptoms 
such as difficulty sustaining attention even for short periods and a slowing of thought processes, which suggest the 
presence of cognitive impairment. A gradual increase of dysphoric reactions and irritability, isolation from friends or 
family members, and suspiciousness may also indicate changes in personality. 
The majority of studies support the existence of a relationship between the state of thyroid function and cognition, in particular 
its relationship to the phenomena of reduced speed of cognitive processes, reduced efficiency in executive functions and  
reduced learning. Hypothyroidism is, in fact, associated with significant neurocognitive deficits involving attention 
and concentration, memory, perceptual function, defective language, executive functions, , disorientation in space 
and time, loss of autonomy, emotional depersonalization and other mental defects. Low thyroid function irrespective 
of age has been found to have a detrimental effect on cognitive functions because hypothyroidism prevents the brain 
from adequately sustaining the energy (glucose)-consuming processes needed for neurotransmission, memory and 
other higher brain functions (Reuters et al., 2012). 
Also the cardiovascular system is directly affected; in overt  hypothyroidism, vital signs reveal bradycardia, diastolic 
hypertension and in severe cases hypotension as a result of the depressed cardiac output. Overall cardiac output is decreased, 
due to the slower heart rate  and decreased contractility (Liappas et al., 2009). 
Neuropsychiatric symptoms tend to improve with therapy and with the restoration of a euthyroid state; although the response is 
variable and full recovery is not entirely certain.  
 
It’s in dispute, however, the extent of the effects that subclinical hypothyroidism actually exercises on mood or cognitive 
function, as well as the effect of therapy on neuropsychiatric symptoms in these cases  (Sharma et al., 2014; Dubbs et al., 
2014 ; Almeida et al., 2007 ; Ergür et al., 2012 ; Joffe et al., 2013; Feb; Parle et al., 2010).  
In the subclinical hypothyroidism all these cohorts of depression-like behavior, sometimes accompanied by subtle 
hyperactivity of Hypothalamic–pituitary–adrenal axis, as was evidenced in a trial conducted on rat model , are 
more nuanced but do not always occur with moderate seriousness (Samuels 2010). 
Rather, there may be symptoms "patchy” and, among these, the most frequent is depression. Controlled studies 
suggest that the cognitive and mood symptoms respond to treatment, although  the data is controversial and methodologically 
limited. In addition, functional neuroimaging data support the existence of cognitive and affective changes and the 
reversibility of these phenomena with the therapy, in  subclinical hypothyroidism as well. This data, however, is not 
uncontroversial. Recent studies on the impact of subclinical hypothyroidism on cognition and mood and epidemiological 
studies designed to assess the normal range of TSH in the population have stimulated considerable debate on the 
identification of the real and appropriate normal range of  TSH. In particular , the doubt arose that patients with overt 
hypothyroidism can be undertreated, and that patients with subclinical hypothyroidism may be substantially outside the range 
of normal thyroid function and should , in fact , be treated (Yamamoto et al., 2012).  
Moreover, next to nothing has been studied about the autonomic characteristics of this clinical population. 
The aim of this study is to assess  psychopathological symptoms and autonomic nervous system activation in patients 
diagnosed with subclinical hypothyroidism, in order to possibly identify typical patterns that could be useful for treatment 
planning and evaluation.  
 
Material and Methods 
 
Since 1998, fifty patients who underwent surgeries at the Department of Endocrinology, University of Pisa, Italy, diagnosed 
with a form of  SHT  were subsequently recruited; at the moment it is impossible to distinguish between the different forms of 
SHT these patients happened to have.  The clinical sample was composed by 50 people (17 males, 33 females) with a 
mean age of 40.7 years (sd: 7.3) while the control group was composed by 50 people ( 22 males, 28 females) with a 
mean age of 24.2 years (sd: 3.4) as shown in TABLE 1. 
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TABLE 1: Sample characteristics 
 Subclinical HT Controls Totals 
M (n//) 17 22 39 
F (n//) 33 28 61 
Totals 50 50 100 
Mean Age (SD) 40.7 (7.3) 24.2 (3.4)  
 
In addition of  routine  blood  tests and hormonal assays, subjects underwent an investigation of the reported symptoms by the 
Crown & Crisp Experiential Index (CCEI, Crown & Crisp, 1979). CCEI is a rating scale able to detect some 
psychopathological symptoms present in the last period in the patient’s life, grouped in six scales: Anxiety, Phobic Anxiety, 
Obsessive Behaviors, Depression, and Hysteria as Emotional Dyscontrol. After the test administration, a psychophysiological 
assessment (PPA) with simultaneous recording of the parameters Skin Conductance Level/ Response (SCL/SCR), Surface 
Frontal Electromyogram (EMG), Peripheral Temperature (PT), Heart Rate (HR). The PPA was divided in the following 4 
phases: 
 
• “Adaptation” (4-5 minutes): Patients were led in a room with a temperature between 18º and 22º and a 
humidity not higher than 50%, and they were invited to seat in an armchair with headrest, wide arms and a reclining 
back. They were informed about the content and the meaning of the procedure and reassured about the fact that the 
procedure was not invasive or harmful. 
At the same time, a psychologist took care of positioning electrodes and transducers, setting up the equipment for 
the registration and monitoring the value progress of the different physiological parameters examining their 
arrangement. 
• “Rest” (6 minutes): the registration started, after telling the patients to close their eyes, to stay still and 
relaxed as much as possible and to signal eventual problems (i.e. need to cough) raising the first finger of the left 
hand  (in that case, the registration was temporarily stopped) 
• “Stress” (4 minutes): Patients were asked to perform a mental task consisting in the subtraction of 13 from 
1007 and from every subsequent result (continuous subtraction) 
• “Recovery” (6 minutes): at the end of the stress presentation patients were asked to stop performing the 
mental task and to rest and relax as much as possible. 
During the PPA the following physiological parameters were recorded: 
Electromyography of the frontal muscle (EMG), whose electric potential was detected using two active electrodes 
located about 1cm over the eyebrows lining with pupils, and one of reference, in the middle of the forehead. 
Heart Rate (HR), detecting the electric potential of the cardiac muscle with the classical bipolar junction used for 
electrocardiograms and calculating the existing time between an R wave (ventricular contraction) and another (Heart 
Rate and Inter Beat Interval). 
Peripheral Temperature (PT), applying a thermistor at the base of the thenar eminence of the dominant hand. 
Skin Conductance Level/Response (SCL/SCR), letting a slight electric current pass between two electrodes located 
on the last phalanx of the dominant hand fingers (in this case, first and second finger). 
All of the PPA was recorded using the Psycholab VD 13 equipment of the SATEM Company in Rome, interfaced 
with a PC.  
 
To assess any differences with the general population, fifty subjects without a personal history of mental and endocrine 
disorders were subsequently recruited (Ge et al., 2013; Davis , Tremont, 2007). This control group did blood test of basal 
values of TSH, total and free T3 and T4, filled out the CCEI questionnaire and underwent the psychophysiological 
examination. Volunteers were recruited from students in the last two years of the degree courses in Medicine and the 
Psychology, Master‘s or Ph.D. level. 
Statistics 
The Kolmogorov Smirnov normality test did not demonstrate any normal distribution of data, so statistical analysis 
has been processed using non-parametric statistics. For the descriptive statistics the Median and the first and third quartile 
have been used, and unpaired comparisons have been made employing the U-Mann Whitney statistical test.  
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Results 
Data shows the same small difference in levels in hormonal assays: TT4 and TT3, FT3, FT4, TSH, but particularly elevated in 
TSH. Obviously values of Controls and Subclinical HT, are significantly different in the two groups, due to the 
presence of the classical pattern of the thyroid dysfunction, as shown in TABLE. 2.  
 
TABLE.2: Median and quartiles (1
st
 and 3
rd
) of the hormonal profiles in subclinical hypothyroidism (SHT) and 
control groups, in brackets reference values for the healthy population. Statistical significance between two groups 
was determined by U-Mann-Witney Test. 
 Controls SHT 
P 
 Median 1
st
 Quartile 3
rd
 Quartile Median 1
st
 Quartile 3
rd
 Quartile 
TT4 
(4,5-12 g/dl) 8.47 7.21 9.30 7 5.57 8.17 <.01 
TT3 
(8-20 ng/dl) 15.77 13.75 16.75 11.80 9.65 13.28 <.001 
FT3 
(2-5,2 pg/ml) 4.09 3.68 4.65 2.99 2.85 3.44 <.001 
FT4 
(7-22 pg/ml) 10.8 8.73 12.79 5.80 5.18 7.42 <.001 
TSH 
(0,3-4,2 mcUl/ml) 1.5 1.1 3 9.78 7.59 11.58 <.0001 
 
As displayed in TABLE 3 and Figure 1, SHT group showed significant higher scores in all the CCEI subscales: 
Anxiety symptom (P<.0001, U-Mann Whitney), Phobia (P<.001, U-Mann Whitney), Obsessive symptoms (P<.001, 
U-Mann Whitney), Somatic Complaints (P<.0001, U-Mann Whitney), Depression symptoms (P<.0001, U-Mann 
Whitney), Hysteria (P<.001, U-Mann Whitney). Furthermore, patients affected by SCH, show a higher level of 
anxious and depressive symptoms and have more somatic complaints than control, and this could be seen as 
behavioral effect of their physiological status. 
 
TABLE  3. CCEI scores (Median) Median and quartiles (1
st
 and 3
rd
) of subclinical hypothyroidism (SHT) and 
control groups for the score of each Crown & Crisp Experiential Index (CCEI) category Legend: A=Anxiety 
symptoms; P=Phobia; O=Obsessive symptoms; S=Somatic Complaints; D Depression Symptoms; H=Hysteria- 
Emotional Discontrol. 
 
 Controls Subclinical HT P 
 Median  1st Quartile 3th Quartile Median  1st Quartile 3th Quartile  
A 5 3 7 9 7 11 <0.0001 
P 4 2 5 6 4 8 <0.001 
O 6 4 7 9 6 10 <0.001 
S 3 2 4 9 7 11 <0.0001 
D 3 2 4 8 7 9 <0.0001 
H 4 2 5 8 6 9 <0.001 
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Figure 1: Median and quartile (1
st
 and 3
rd
) of subclinical hypothyroidism (SHT) and control groups for the score of 
each Crown & Crisp Experiential Index (CCEI) category: A Anxiety; P Phobia; O Obsession; S Somatic Complaints; 
D Depression; H Hysteria (emotional discontrol). Statistical significance, U-Mann-Witney Test: (P<.0001), + 
(P<.001) 
 
 
At the autonomic level, SHT subjects showed a general pattern of excessive arousal with statistically significant 
differences among groups in SCL/SCR, HR, and PT (always P<.0001, U-Mann Whitney). In particular, in SHT 
group there is a typical pattern of elevated values in HR, SCL, EMG, and lower values in PT, characteristic of a 
whole autonomic hyper arousal (TABLE 4) This result is completely unexpected, since the behavioral pattern of 
these patients is more depressive-like, and usually it is mirrored by an autonomic hypoactivated profile. 
This result is completely unexpected, since the behavioral pattern of these patients is more depressive-like, and 
usually it is mirrored by an autonomic hypoactivated profile. 
 
TABLE 4.  PPA Scores (Median) Legend: EMG= Frontal Muscle Surface EMG; SCL= Skin Conductance Level;        
PT =Peripheral Temperature; HR =Heart Rate. Median and quartiles (1
st
 and 3
rd
) of PPA Scores. Statistical 
significance between two groups was determined by U-Mann-Witney Test. 
 Controls Subclinical HT P 
 Median  1st Quartile 3th Quartile Median  1st Quartile 3th Quartile  
EMG 2.18 1.77 3.10 3.6 3 4.25 <0.0001 
SCL 4.88 3.76 5.41 9.79 7.20 12 <0.0001 
PT 33.8 33.35 34.40 30.4 29.40 31.7 <0.0001 
HR 70 66 47 75 69 78 <0.0001 
 
Discussion and Conclusion 
Two different and important kinds of data seem to characterize the examined sample of subject with SHT: psychopathological 
reported symptoms and the pattern of autonomic arousal. The most  relevant  psychic symptoms seem to be anxiety and 
depression immediately followed by somatic complaints.  If the last one could be partially explained  by the recent medical 
diagnosis, and the presence of depressive symptoms is in total accord with the evidence collected in the literature on symptoms 
reported  in overt hypothyroidism  interestingly  anxiety symptoms seem to have a prevalence on depressive ones. (Cooper, 
Biondi, 2012; Almeida et al.,2007; Monzani et al., 1991; Monzani et al, 1993 May; Chueire et al., 2007; Davis et al., 2003 
; De Jongh et al., 2011 ; Demartini et al., 2010 ). 
 This data is not supported by previous research, but the anxious symptomatology reported by these patients could be the 
cognitive and self-reported manifestation of the autonomic hyperactivation detected in this sample through the PPA.  
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In fact, despite one of the physical consequences of clinical hypothyroidism is a general low level of heart rate (HR) (Reuters 
et al., 2012 ) compared to people  selected from the general population, the examined SHT sample revealed an autonomic 
unbalance characterized by moderate high values in ¾ of  the parameters, among which, the HR. 
A possible first interpretation of the results obtained is that in this kind of slight form of hypothyroidism, the body, especially 
during the first period of the endocrine dysfunction, tries to support and  integrate the general lack of energy caused by the 
hypothyroidism, with an acceleration of the autonomic activity. If this data will be confirmed by other prospective studies, 
with groups of subjects that are more balanced, this data could represent a very important discovery with a useful fallout in the 
clinical practice. In fact, one of the most important clinical consequences of overt hypothyroidism, also slightly present  in 
subclinical hypothyroidism, is the presence of depressive symptoms, asthenia, apathy, so often treated with antidepressants 
(Dubbs , Spangler, 2014 ). 
If this solution could be helpful in general, in case of autonomic hyper arousal, antidepressant could cause several problems in 
the ménage of the case with negative consequences due, e.g., to the rising of hypo maniacal symptoms. A brief 
psychophysiological assessment seems therefore to be a good and low expensive methodology in order to better understand 
the clinical picture and better evaluate how far therapy should last. Moreover, the PPA could be a useful tool to model the 
treatment plan according to the patient’s specific physiological necessities and a way to track a patient’s autonomic balance, 
thus optimizing treatment effectiveness and preventing possible secondary effects linked to overt hypothyroidism, like 
depressive syndromes or heart failures. 
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